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To suggest a topic for this series, please email us at
easilymissed@bmj.com.
A19 year old student phoned an official health service telephone
helpline with a 10 day history of aching legs, vomiting,
diarrhoea, and abdominal pain. She mentioned a recent trip to
Uganda but was reassured and told she had “flu.” The next day
her boyfriend took her to see her doctor, where she mentioned
general malaise, tiredness, and occasional nausea; the doctor
diagnosed a viral illness and advised her to keep taking
paracetamol. Three days later a friend found her dead in bed in
her university halls of residence. The coroner recorded death
due to cerebral malaria.1
What is malaria?
Malaria is an infection caused by protozoa of the genus
Plasmodium. Five species infect humans (P falciparum, P vivax,
P ovale, P malariae, and P knowlesi). Most of the fatal cases
are caused by P falciparum.
Why is malaria missed in non-endemic
countries?
As illustrated by the case described here, the symptoms of
malaria are non-specific and can easily be mistaken for a viral
illness such as influenza, unless clinicians think to ask patients
whether they have travelled abroad.
A retrospective observational study of 191 deaths due to malaria
in the United Kingdom from 1987 to 2006 found that the case
fatality was inversely related to incidence, suggesting that cases
were more easily missed by clinicians unaccustomed to seeing
this disease.4 A retrospective series of 39 cases of malaria
diagnosed in Sheffield from 2000 to 2005 found that eight of
these patients had presented to health professionals with
symptoms of malaria but were not immediately referred to
hospital or for a diagnostic test, suggesting that the diagnosis
of malaria had not been considered.6A retrospective case review
of 211 children admitted to hospital with malaria in east London
found that 114 had initially presented to their doctor, but malaria
was suspected at the first visit in only 32% of these, and
diagnosis was delayed in 53%, by one to 14 days.7
Why does this matter?
If untreated, malaria can be rapidly fatal, particularly in
non-immune patients. Delay in diagnosis is associated with an
increased risk of severe malaria and death.5 8 The overall case
fatality rate from malaria in the United Kingdom is 0.73%,4 but
for cases with signs of severe malaria (box) this may reach
10-20%.9 Severe complications and death may occur within
24-48 hours of onset of symptoms.10 11 Early diagnosis and
appropriate treatment are therefore crucial.
How is malaria diagnosed?
Clinical
Question anyone presenting with a history of fever or flu-like
symptoms about travel to malaria endemic countries within the
past year. Investigate urgently those returning from a malaria
endemic area, regardless of whether they have taken malaria
prophylaxis. Intermittent fever may be a feature of malaria, so
temperature may be normal at the time of examination. A case
series of 482 patients in the United States found that half of
adult patients were not febrile when they presented, although
most had a history of fever.12 Other common symptoms include
vomiting, diarrhoea, headache, and myalgia.5 12 Most patients
with P falciparum present within six months of returning from
abroad, although later presentations may occur. The box shows
the features of severe disease.
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How common is malaria?
• Worldwide over 200 million cases of malaria occur annually and 0.5-1 million deaths, 90% of which are among children in Africa2
• Plasmodium falciparum accounted for about 70% of the 1677 cases notified in the United Kingdom in 2011, whereas 25% of cases
were due to P vivax3
• Of the 191 deaths from malaria in the United Kingdom from 1987 to 2006, 184 were due to P falciparum4
• About 20% of imported malaria cases are in children5
Definition of severe malaria9
In patients with Plasmodium falciparum asexual parasitaemia and no other obvious cause of symptoms, severe malaria is defined by one
or more of the following features:
Clinical features
Impaired consciousness or coma from which patients cannot be roused
Prostration—that is, generalised weakness such that that patients cannot sit up unaided
Failure to feed
Multiple convulsions—more than two episodes in 24 hours
Deep breathing, respiratory distress (acidotic breathing)
Circulatory collapse or shock, systolic blood pressure <70 mm Hg in adults and <50 mm Hg in children
Clinical jaundice plus evidence of other vital organ dysfunction
Haemoglobinuria
Abnormal spontaneous bleeding
Pulmonary oedema (radiological)
Laboratory findings
Haematology
Severe normocytic anaemia (haemoglobin level <50 g/L, packed cell volume <15%)
Hyperparasitaemia (>2% or 100 000/μL in areas of low intensity of transmission; >5% or 250 000/μL in areas of high and stable intensity
of transmission)
Biochemistry
Hypoglycaemia (blood glucose level <2.2 mmol/L or <40 mg/dL)
Renal impairment (serum creatinine level >265 μmol/L)
Metabolic acidosis (plasma bicarbonate level <15 mmol/L)
Hyperlactataemia (lactate >5 mmol/L)
Urine
Haemoglobinuria
Investigations
It is preferable to refer all patients with suspected malaria to
hospital immediately for further investigation because of the
risk of rapid progression of falciparummalaria. However, if the
patient is relatively well and it is possible to obtain results
rapidly (the same day), it may be reasonable to investigate in a
primary care setting. This calls for some clinical judgment. If
the risk of malaria is low and the patient is not severely ill,
outpatient testing with next day results may be acceptable, but
the patient should then be advised to reconsult rapidly if there
is any worsening of symptoms.
The clinician should request an urgent full blood count and
“malaria thick and thin films” (both on the same EDTA sample).
Although microscopy is the standard diagnostic method, low
density infection may be missed,13 particularly if microscopists
are inexperienced or if patients have taken an antimalarial or
an antibiotic with antimalarial activity. Therefore, if the first
slide gives a negative result, films should be repeated after 12-24
hours, and again after another 24 hours. The likelihood of
malaria is low if experienced microscopists find three
consecutive negative blood film results.14
In the United Kingdom some haematology laboratories may
also be able to perform a rapid diagnostic test. These tests are
based on detection of parasite antigens or enzymes; a recent
Cochrane review found that the sensitivity and specificity of
the most common rapid diagnostic tests were both 95%,
compared with microscopy.15 Rapid diagnostic tests are useful
in increasing speed of diagnosis, even in non-endemic countries16
and, if available, can be used as an adjunct to microscopy,
although they cannot replace it. All positive malaria test results
should be telephoned immediately to the requesting doctor and
communicated by the doctor to the patient.14.
Thrombocytopenia is common in acutemalaria, and, if otherwise
unexplained, may be an important clue even if the blood film
has been reported as negative. A prospective study looking at
returning travellers with fever found that leucocyte counts
<10×109/L, platelet counts <150×109/L, and haemoglobin levels
<120 g/L were all associated with an increased probability of
malaria. Thrombocytopenia was the best predictor, with a
positive likelihood ratio of 11.17
How is malaria managed?
Seek expert advice on treatment, particularly if there are signs
of complications. In the primary care setting, if there are any
signs of severe malaria, refer the patient to hospital as an
emergency and treat any complications (for example, shock,
hypoglycaemia, convulsions) while awaiting transfer.
Most patients with falciparum malaria need admission to
hospital, although recent evidence has suggested that a small
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selected group with uncomplicated falciparum malaria can be
treated safely as outpatients.18 19 Those with uncomplicated
non-falciparum infections can usually bemanaged as outpatients
provided they are able to take oral drugs. Mixed infections can
occur and P falciparum may be missed or misdiagnosed.
Therefore it is sensible to have a low threshold for admission
and to advise all those treated as outpatients to seek further
medical attention urgently if they deteriorate. It is also advisable
to review all patients with malaria 1-2 weeks after completion
of treatment.18 19
Because of the risk of increasing drug resistance, the World
Health Organization now recommends that uncomplicated P
falciparum malaria should be treated with artemisinin
combination therapies.9 Recent studies have proved that
intravenous artesunate is more effective than quinine for the
treatment of severe malaria,20 21 but UK guidelines still
recommend quinine because artesunate is unlicensed in the
European Union.14 These guidelines are, however, currently
under review. Chloroquine is usually effective for
non-falciparummalarias; however, chloroquine resistant P vivax
is increasingly prevalent in some areas (for example, Indonesia,
Peru, and Oceania).9 In addition, patients with P vivax or P ovale
infections should have their glucose 6 phosphate dehydrogenase
(G6PD) status checked and, unless significantly G6PD deficient,
should also be treated with an appropriate course of primaquine
to reduce the likelihood of relapses.22
UK guidelines for malaria treatment14 and a useful management
algorithm are available at www.hpa.org.uk/Topics/InfectiousDiseases/
InfectionsAZ/Malaria/Guidelines/mala20guidelinesTreatment/.
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Key points
• If patients have fever, history of fever, or flu-like symptoms, always ask about travel to a malaria endemic country within the past year
• If malaria is suspected, request urgent thick and thin malaria films (three negative films results on consecutive days are needed to
exclude the diagnosis) and a full blood count (thrombocytopaenia is common in acute malaria)
• If there are any signs of severe malaria, admit as an emergency
For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2013;346:f3214 doi: 10.1136/bmj.f3214 (Published 30 May 2013) Page 4 of 3
PRACTICE
